×
908 Devices Receivables 2020-2024 | MASS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
908 Devices receivables from 2020 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
908 Devices Receivables 2020-2024 | MASS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
908 Devices receivables from 2020 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$233.1B
Intuitive Surgical (ISRG)
$171.3B
Alcon (ALC)
$47.7B
IQVIA Holdings (IQV)
$44.2B
IDEXX Laboratories (IDXX)
$42.1B
Edwards Lifesciences (EW)
$40.7B
DexCom (DXCM)
$27.8B
STERIS (STE)
$23.5B
SONOVA HOLDING (SONVY)
$20.8B
Waters (WAT)
$19.8B
Hologic (HOLX)
$19B
Sysmex ADR (SSMXY)
$12.3B
Fresenius Medical Care AG KGaA (FMS)
$12.2B
Teleflex (TFX)
$11.4B
Globus Medical (GMED)
$9.4B
Penumbra (PEN)
$7.6B
Glaukos (GKOS)
$6.7B
Masimo (MASI)
$6.1B
TransMedics (TMDX)
$5.2B
PROCEPT BioRobotics (PRCT)
$4.3B
Integer Holdings (ITGR)
$4.3B
Tandem Diabetes Care (TNDM)
$2.8B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.6B
Inari Medical (NARI)
$2.6B
Elekta AB (EKTAY)
$2.6B
Nihon Kohden (NHNKY)
$2.5B
RxSight (RXST)
$2B
Integra LifeSciences Holdings (IART)
$1.4B
Pulse Biosciences (PLSE)
$1.2B